Floatz logo

Gentamicin

Choledocholithiasis

National University of MalaysiamixturePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Choledocholithiasis cohort.

Same molecule, other indications

Gentamicin is also rated in:

bronchiectasisDormant
BB
Indicative · Phase 4
65 / 100
View asset →
breast cancerActive
B
Indicative · Phase 4
56 / 100
View asset →
cholestasisActive
CCC
Indicative · Phase 2
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →